Downstream Processing Featured Articles

  1. Unraveling The Molecular Roots Of Down Syndrome 3/24/2013

    What is it about the extra chromosome inherited in Down syndrome—chromosome 21—that alters brain and body development? Researchers have new evidence that points to a protein called sorting nexin 27, or SNX27.

  2. Cangene Announces Closing Of Acquisition Of Late Stage Hemophilia B Product 2/20/2013

    Cangene Corporation (Cangene) today announces the closing of the acquisition of the investigational hemophilia compound IB1001 and certain other assets from Ipsen and Inspiration Biopharmaceuticals, Inc. in connection with Inspiration's bankruptcy proceedings.

  3. Nearly 1,000 Medicines In Development To Help Patients In Their Fight Against Cancer 5/31/2012

    America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of canceraffecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

  4. Antibody Evolution Could Guide HIV Vaccine Development 4/4/2013

    Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

  5. NIH-Supported Study Shows How Immune Cells Change Wiring Of The Developing Mouse Brain 5/23/2012

    Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. 

  6. Thermo Fisher Scientific Introduces Data System To Unite Chromatography And Mass Spectrometry 3/18/2013

    Thermo Fisher Scientific Inc., the world leader in serving science, recently introduced the next generation of its gold-standard Chromeleon chromatography data system (CDS), which now supports mass spectrometry along with mainstream front-end separation techniques in the same software package.

  7. 3M Launches Large-Scale, Single-Use, Multi-Round Depth Filtration System 6/14/2012

    3M expanded its portfolio of Encapsulated Zeta Plus™ single-use depth filtration products to include our Model# 16EZC Multi-Round Holder.

  8. Selexys Pharmaceuticals Completes $23M Equity Financing And Signs Agreement With Global Pharmaceutical Company 9/20/2012

    Selexys Pharmaceuticals, Corp., announced today that it has successfully completed a $23 million Series A equity financing, led by MPM Capital. Additionally, Selexys entered into an agreement with Novartis Pharmaceuticals whereby Novartis has been granted an exclusive option to acquire Selexys and its lead asset, the anti-P-selectin antibody SelG1, following the successful completion of a Phase 2 clinical study in patients with sickle cell disease.

  9. Sanford-Burnham Research Projects Selected To Go To Space 11/29/2012

    We’re excited to announce recently that two of our research teams have won Space Florida’sInternational Space Station (ISS) Research Competition. Eight teams were selected from a pool of international applicants to send experiments to space in late 2013.

  10. Frost & Sullivan Lauds Pfenex Inc. For Developing A Protein Expression Platform That Delivers Unparalleled Success And Speed 6/5/2012

    Based on its comprehensive  TEAM Research rigorous 10 step evaluation methodology, Frost & Sullivan has awarded Pfenex Inc. with the 2012 North American Enabling Technology Award in Microbial Expression Technology.